These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9634126)

  • 1. Laryngeal manifestations of vasculitic disease.
    Astor FC; Eidelman FJ; Hanft KL; Alghraoui F
    South Med J; 1998 Jun; 91(6):588-91. PubMed ID: 9634126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of anti-neutrophil cytoplasmic autoantibody tests in the diagnosis of idiopathic necrotizing-crescentic glomerulonephritis and renal vasculitis.
    Velosa JA; Homburger HA; Holley KE
    Mayo Clin Proc; 1993 Jun; 68(6):561-5. PubMed ID: 8497133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease.
    Bienaimé F; Clerbaux G; Plaisier E; Mougenot B; Ronco P; Rougier JP
    Am J Kidney Dis; 2007 Nov; 50(5):821-5. PubMed ID: 17954295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineutrophil cytoplasmic autoantibody--associated glomerulonephritis: potentially reversible disease.
    Wen SF
    J Formos Med Assoc; 1994 Jul; 93(7):545-61. PubMed ID: 7866052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANCA-associated renal vasculitis following anti-tumor necrosis factor alpha therapy.
    Simms R; Kipgen D; Dahill S; Marshall D; Rodger RS
    Am J Kidney Dis; 2008 Mar; 51(3):e11-4. PubMed ID: 18295046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pauci-immune necrotizing glomerulonephritis complicating rheumatoid arthritis.
    Qarni MU; Kohan DE
    Clin Nephrol; 2000 Jul; 54(1):54-8. PubMed ID: 10939757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nephrological view of the classification of vasculitis.
    Falk RJ; Jennette JC
    Adv Exp Med Biol; 1993; 336():197-208. PubMed ID: 8296608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does truly 'idiopathic' crescentic glomerulonephritis exist?
    Angangco R; Thiru S; Esnault VL; Short AK; Lockwood CM; Oliveira DB
    Nephrol Dial Transplant; 1994; 9(6):630-6. PubMed ID: 7970088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis.
    Neumann I; Regele H; Kain R; Birck R; Meisl FT
    Nephrol Dial Transplant; 2003 Mar; 18(3):524-31. PubMed ID: 12584274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic predictive value of ANCA serology.
    Jennette JC; Wilkman AS; Falk RJ
    Kidney Int; 1998 Mar; 53(3):796-8. PubMed ID: 9507231
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineutrophil cytoplasmic antibody-associated vasculitis and chronic lymphocytic leukemia: A rare association.
    Nagarajan M; Dhanapriya J; Dineshkumar T; Sakthirajan R; Balasubramaniyan T; Gopalakrishnan N
    Indian J Pathol Microbiol; 2017; 60(2):300-301. PubMed ID: 28631665
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasmic antibodies-related necrotising crescentic glomerulonephritis in a patient with rheumatoid arthritis.
    Sugimoto T; Koyama T; Kanasaki K; Morita Y; Yokomaku Y; Deji N; Tanaka Y; Uzu T; Kashiwagi A
    Nephrology (Carlton); 2006 Oct; 11(5):478. PubMed ID: 17014567
    [No Abstract]   [Full Text] [Related]  

  • 15. ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective.
    Falk RJ; Nachman PH; Hogan SL; Jennette JC
    Semin Nephrol; 2000 May; 20(3):233-43. PubMed ID: 10855933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case of ANCA-associated glomerulonephritis detected at an early phase].
    Hayamai N; Kashiwagi T; Iino Y; Kitamura H; Kurihara S
    Nihon Jinzo Gakkai Shi; 2005; 47(5):536-9. PubMed ID: 16130409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An index for renal outcome in ANCA-associated glomerulonephritis.
    Vergunst CE; van Gurp E; Hagen EC; van Houwelingen HC; Hauer HA; Noël LH; Waldherr R; Ferrario F; van der Woude FJ; Bruijn JA; Bajema IM;
    Am J Kidney Dis; 2003 Mar; 41(3):532-8. PubMed ID: 12612975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANCA-positive periaortic vasculitis: does it fall within the spectrum of vasculitis?
    Vaglio A; Manenti L; Allegri L; Ferrozzi F; Corradi D; Buzio C
    J Intern Med; 2002 Mar; 251(3):268-71. PubMed ID: 11886487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-neutrophil cytoplasmic antibodies: a new class of autoantibodies in glomerulonephritis, vasculitis and other inflammatory disorders.
    Tervaert JW; Stegeman CA; Brouwer E; Mulder AH; Limburg PC; Kallenberg CG
    Neth J Med; 1994 Dec; 45(6):262-72. PubMed ID: 7838242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p-ANCA with myeloperoxidase antibodies and c-ANCA with proteinase 3 antibodies define a different vasculitis entity in patients with renal involvement.
    Dringenberg C; Apenberg S; Andrassy K
    Adv Exp Med Biol; 1993; 336():445-7. PubMed ID: 8296653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.